A new patent filed by the Uriage Dermatological Laboratories combines TLR2-Regul complex and SK5R complex (Specific-Kallikrein-5-Regulator) to regulate the activity of Kallikrein-5, a protease that causes inflammation and vascular problems, and provide highly effective soothing action.
Protects the cutaneous barrier of the skin
The association of the TLR2-Regul complex and the SK5R complex, (Specific-Kallikrein-5-Regulator), a new patent from Uriage Dermatological Laboraties, regulates the activity of Kallikréine-5 to diminish redness and soothe dry skin.

 A rich and non-greasy cream that diminishes redness caused by dry skin. Upon application, comfort is immediately restored to skin, leaving it soft, perfectly moisturized and soothed.